Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00845013 · ClinicalTrials.gov registry record
Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 365
- Enrollment target
NCT00845013: Completed study, sponsored by University of California, San Francisco.
NCT00845013 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 365 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00845013 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 365 participants
- Enrollment target
Study Summary
The purpose of this study is to describe the epidemiology of pulmonary hypertension in individuals with HIV infection and to investigate its pathogenesis. We propose to conduct a prospective observational cohort study to determine the association between highly active antiretroviral therapy (HAART) and viral suppression in HIV-infected patients who have been identified to have pre-clinical pulmonary hypertension (Aim 1). In addition, we will investigate the mechanistic role of the HIV-1 Nef protein and HHV-8 infection in the development and progression of pulmonary hypertension in individuals with HIV (Aim 2). We will also investigate endothelial function in HIV-infected patients with pulmonary hypertension (Aim 3).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2007-11 |
| Est. Completion | 2021-01 |
What the finished NCT00845013 record still lists
NCT00845013 is an observational study that tracks outcomes without assigning an intervention. The registered 365 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00845013 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00845013 about?
NCT00845013 is a clinical study titled "Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension". The purpose of this study is to describe the epidemiology of pulmonary hypertension in individuals with HIV infection and to investigate its pathogenesis. We propose to conduct a prospective observational cohort study to determine the association between highly active antiretroviral therapy (HAART) ...
What is the current status of trial NCT00845013?
This trial is currently completed. The enrollment target is 365 participants. The study started on 2007-11. Estimated completion is 2021-01.
Who is sponsoring clinical trial NCT00845013?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04049604 · 365 participants · NA
IDENTIFY Study: Natural History of Maternal Neoplasia
- NCT05065840 · 365 participants · NA
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
- NCT05303519 · 365 participants · Phase 3
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- NCT05592626 · 365 participants · Phase 1
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia